WO2024134512 - LIPID NANOPARTICLE COMPOSITION
National phase entry:
Publication Number
WO/2024/134512
Publication Date
27.06.2024
International Application No.
PCT/IB2023/062968
International Filing Date
20.12.2023
Title **
[English]
LIPID NANOPARTICLE COMPOSITION
[French]
COMPOSITION DE NANOPARTICULES LIPIDIQUES
Applicants **
SEQIRUS INC.
Inventors
NOLASCO, Jonathan
HARRIRI, Ghazal
Priority Data
63/476,217
20.12.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3486 | |
| EPO | Filing, Examination, Granting | 26198 | |
| Japan | Filing, Examination, Granting | 2896 | |
| South Korea | Filing, Examination, Granting | 3597 | |
| USA | Filing, Examination, Granting | 11960 |
Total:
48,137
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure relates compositions of RNA encapsulated in lipid nanoparticles and methods of producing the same The compositions can be used for delivery of mRNA to a subject. The lipid nanoparticles have improved properties for delivery of biologically active agents, such as RNA.[French]
La présente invention concerne des compositions d'ARN encapsulées dans des nanoparticules lipidiques et des procédés de production de celles-ci. Ces compositions peuvent être utilisées pour la délivrance d'ARNm à un sujet. Les nanoparticules lipidiques ont des propriétés améliorées pour la délivrance d'agents biologiquement actifs, tels que l'ARN.